This highlights the need for greater awareness of the disorder and underscores the potential heterogeneity in clinical presentation among individuals with MCT8 deficiency, even those with the same pathogenic variant. The gene discussed is SLC16A2; the disease is hyperinsulinemic hypoglycemia, familial, 4.